Immunological studies into the mechanisms of action of cyclosporin A in psoriasis

Seven chronic plaque psoriasis patients were treated with cyclosporin A (CsA, 2.5-5.0 mg/kg/day). A marked resolution of psoriasis was observed within 4 weeks of treatment. Immunophenotypic analysis of patients' peripheral blood mononuclear cells (PBML) before and during CsA therapy revealed no...

Full description

Bibliographic Details
Main Author: Horrocks, C.
Published: University of Aberdeen 1992
Subjects:
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.592590